Bill Meury

Chief Executive Officer, Incyte

Wilmington, Delaware

About

Bill Meury is the Chief Executive Officer and a director of Incyte, a biopharmaceutical company based in Wilmington, Delaware that discovers, develops and commercializes therapeutics. He joined the company in June 2025 and leads it as CEO. Before Incyte he was the chief executive of two other drug developers, Anthos Therapeutics and Karuna Therapeutics, and he held a senior commercial role at Allergan.

Meury began his career in public accounting at Reznick, Fedder & Silverman and in financial reporting at MCI Communications, then joined Forest Laboratories in 1993, where he became Executive Vice President, Sales and Marketing. He held Allergan roles from 2014 to 2016 and was its Chief Commercial Officer from 2016 to 2020. He then worked as a partner at Hildred Capital Management. At Incyte he followed Hervé Hoppenot, who retired as CEO in June 2025. Other biotech chief executives with pages on Whoo include Kyle Gano of Neurocrine Biosciences and Michael Morrissey of Exelixis.

He was CEO of Karuna Therapeutics from January 2023 to March 2024, when Bristol-Myers Squibb acquired it, and of Anthos Therapeutics from April 2024 to April 2025, when Novartis acquired it.

Whoo compiled this page from public sources: Incyte 2026 proxy statement (SEC), Incyte Form 10-Q, September 2026 (SEC), Wikipedia: Incyte. It is not affiliated with or endorsed by Bill Meury. Are you Bill Meury? Claim this page, or write to [email protected] to correct or remove it. Last updated: 2026-11-18.

Want a page like this? Create yours from your résumé.

Experience

Chief Executive Officer — Incyte


2025 – Present | Wilmington, Delaware

  • Joined Incyte in June 2025 and serves as CEO and director
  • President and CEO — Anthos Therapeutics


    April 2024 – April 2025

  • Led the private company until Novartis acquired it
  • President and CEO — Karuna Therapeutics


    January 2023 – March 2024

  • Led the public company until Bristol-Myers Squibb acquired it
  • Partner — Hildred Capital Management


    May 2020 – December 2022

    Chief Commercial Officer — Allergan


    May 2016 – May 2020

  • Held earlier Allergan roles from 2014 to 2016
  • Executive Vice President, Sales and Marketing — Forest Laboratories


    1993 – 2014

  • Joined Forest in 1993; Actavis acquired the company in July 2014

Education

Education


Not published in sources

Projects